A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial)

Table 1 Baseline/screening and outcome measures

Time point	0	0	1	2	4	Completed by
Months post randomisation	Pre-baseline/screening	Baseline	Mid-treatment (4 weeks)	Complete-treatment (8 weeks)	8 weeks after completion (16 weeks)	Completed by
Consent	X					P
GAD7		X	X	X	X	R and P
WSAS		X	X	X	X	R and P
EQ-5D-5L		X	X	X	X	R and P
CSRI		X	X	X	X	R and P
SCID-5-RV	X (major depressive episode criteria)	X				R and P
GRID-HAMD		X	X	X	X (primary outcome)	R and P
Randomisation		X				R
PHQ-9	X		X	X	X	R and P

ISSN: 1745-6215